| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/SYN.890010504 |
| P698 | PubMed publication ID | 3509803 |
| P2093 | author name string | Vale WW | |
| Price DL | |||
| Whitehouse PJ | |||
| Walker LC | |||
| Struble RG | |||
| Powers RE | |||
| DeSouza EB | |||
| P2860 | cites work | Reductions in corticotropin releasing factor-like immunoreactivity in cerebral cortex in Alzheimer's disease, Parkinson's disease, and progressive supranuclear palsy. | Q53193396 |
| Neurotransmitter receptors in olivopontocerebellar atrophy: an autoradiographic study | Q48383864 | ||
| P433 | issue | 5 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| immunohistochemistry | Q899285 | ||
| P304 | page(s) | 405-410 | |
| P577 | publication date | 1987-01-01 | |
| P1433 | published in | Synapse | Q7662025 |
| P1476 | title | Immunohistochemical study of neurons containing corticotropin-releasing factor in Alzheimer's disease | |
| P478 | volume | 1 |
| Q36495570 | 5 Neuropeptides and neurotransmitters in Alzheimer's disease: focus on corticotrophin releasing factor |
| Q48771659 | Acute stress-induced increases in thalamic CRH mRNA are blocked by repeated stress exposure. |
| Q40780751 | Alterations in neuropeptides in aging and disease. Pathophysiology and potential for clinical intervention |
| Q42504716 | CRH defects in Alzheimer's and other neurologic diseases |
| Q30754529 | Corticotropin-releasing factor receptor-1 antagonism mitigates beta amyloid pathology and cognitive and synaptic deficits in a mouse model of Alzheimer's disease |
| Q44934002 | Corticotropin-releasing factor receptors differentially regulate stress-induced tau phosphorylation. |
| Q48178777 | Corticotropin-releasing hormone neurons in hypertensive patients are activated in the hypothalamus but not in the brainstem |
| Q24303455 | Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease |
| Q35623440 | Immunolocalization of Kisspeptin Associated with Amyloid-β Deposits in the Pons of an Alzheimer's Disease Patient |
| Q35694088 | Impact of CRFR1 Ablation on Amyloid-β Production and Accumulation in a Mouse Model of Alzheimer's Disease |
| Q52243742 | Implications of multiple transmitter system lesions for cholinomimetic therapy in Alzheimer's disease. |
| Q35158376 | Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases? |
| Q41893464 | Longitudinal brain corticotropin releasing factor and somatostatin in a transgenic mouse (TG2576) model of Alzheimer's disease |
| Q36302335 | Metabolic and Non-Cognitive Manifestations of Alzheimer's Disease: The Hypothalamus as Both Culprit and Target of Pathology |
| Q37793507 | Neuronal responses to injury and aging: lessons from animal models |
| Q41478899 | Neuropeptides and Alzheimer's disease pathology |
| Q47686059 | Physiological and neurochemical aspects of corticotropin-releasing factor actions in the brain: the role of the locus coeruleus |
| Q40971048 | Postmortem and cerebrospinal fluid studies of corticotropin-releasing factor in humans |
| Q44800050 | Substance P-like immunoreactive neurons are depleted in Alzheimer's disease cerebral cortex |
| Q36714050 | Synaptic physiology of central CRH system |
| Q48305886 | The Corticotropin Releasing Factor Receptor 1 in Alcohol Use Disorder: Still a Valid Drug Target? |
Search more.